These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 2904493)

  • 1. Neuroprotective effects of MK-801 in vivo: selectivity and evidence for delayed degeneration mediated by NMDA receptor activation.
    Foster AC; Gill R; Woodruff GN
    J Neurosci; 1988 Dec; 8(12):4745-54. PubMed ID: 2904493
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CGS-19755 and MK-801 selectively prevent rat striatal cholinergic and gabaergic neuronal degeneration induced by N-methyl-D-aspartate and ibotenate in vivo.
    Schoepp DD; Salhoff CR; Hillman CC; Ornstein PL
    J Neural Transm Gen Sect; 1989; 78(3):183-93. PubMed ID: 2553073
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparative analysis of the neuroprotective properties of competitive and uncompetitive N-methyl-D-aspartate receptor antagonists in vivo: implications for the process of excitotoxic degeneration and its therapy.
    Massieu L; Thedinga KH; McVey M; Fagg GE
    Neuroscience; 1993 Aug; 55(4):883-92. PubMed ID: 7694181
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Systemic administration of MK-801 prevents N-methyl-D-aspartate-induced neuronal degeneration in rat brain.
    Foster AC; Gill R; Kemp JA; Woodruff GN
    Neurosci Lett; 1987 May; 76(3):307-11. PubMed ID: 3295603
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protection Against N-methyl-D-aspartate Receptor-Mediated Neuronal Degeneration In Rat Brain by 7-chlorokynurenate and 3-amino-1-hydroxypyrrolid-2-one, Antagonists at The Allosteric Site for Glycine.
    Foster AC; Willis CL; Tridgett R
    Eur J Neurosci; 1990; 2(3):270-277. PubMed ID: 12106053
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An investigation of the mechanisms of delayed neurodegeneration caused by direct injection of quinolinate into the rat striatum in vivo.
    Bakker MH; Foster AC
    Neuroscience; 1991; 42(2):387-95. PubMed ID: 1680225
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuronal damage induced by beta-N-oxalylamino-L-alanine, in the rat hippocampus, can be prevented by a non-NMDA antagonist, 2,3-dihydroxy-6-nitro-7-sulfamoyl-benzo(F)quinoxaline.
    Willis CL; Meldrum BS; Nunn PB; Anderton BH; Leigh PN
    Brain Res; 1993 Nov; 627(1):55-62. PubMed ID: 7507397
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Kynurenic acid and quinolinic acid act at N-methyl-D-aspartate receptors in the rat hippocampus.
    Ganong AH; Cotman CW
    J Pharmacol Exp Ther; 1986 Jan; 236(1):293-9. PubMed ID: 2867215
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Peripheral type benzodiazepine binding sites are a sensitive indirect index of neuronal damage.
    Benavides J; Fage D; Carter C; Scatton B
    Brain Res; 1987 Sep; 421(1-2):167-72. PubMed ID: 2891401
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 2,3-Dihydroxy-6-nitro-7-sulfamoyl-benzo(f)quinoxaline protects against both AMPA and kainate-induced lesions in rat striatum in vivo.
    Massieu L; Tapia R
    Neuroscience; 1994 Apr; 59(4):931-8. PubMed ID: 7520137
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Non-NMDA antagonists protect against kainate more than AMPA toxicity in the rat hippocampus.
    Moncada C; Arvin B; Le Peillet E; Meldrum BS
    Neurosci Lett; 1991 Dec; 133(2):287-90. PubMed ID: 1816508
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential sparing of somatostatin-neuropeptide Y and cholinergic neurons following striatal excitotoxin lesions.
    Beal MF; Kowall NW; Swartz KJ; Ferrante RJ; Martin JB
    Synapse; 1989; 3(1):38-47. PubMed ID: 2563916
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of N-methyl-D-aspartate evoked sodium flux by MK-801.
    Ransom RW; Stec NL
    Brain Res; 1988 Mar; 444(1):25-32. PubMed ID: 3282615
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuroprotectant effects of LY274614, a structurally novel systemically active competitive NMDA receptor antagonist.
    Schoepp DD; Ornstein PL; Salhoff CR; Leander JD
    J Neural Transm Gen Sect; 1991; 85(2):131-43. PubMed ID: 1834088
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Developmental changes in the effects of drugs acting at NMDA or non-NMDA receptors on synaptic transmission in the chick cochlear nucleus (nuc. magnocellularis).
    Zhou N; Parks TN
    Brain Res Dev Brain Res; 1992 Jun; 67(2):145-52. PubMed ID: 1380899
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dextromethorphan does not protect against quinolinic acid neurotoxicity in rat striatum.
    Engber TM; Chase TN
    Neurosci Lett; 1988 Dec; 95(1-3):269-74. PubMed ID: 2976130
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Systemic administration of MK-801 protects against N-methyl-D-aspartate- and quisqualate-mediated neurotoxicity in perinatal rats.
    McDonald JW; Silverstein FS; Cardona D; Hudson C; Chen R; Johnston MV
    Neuroscience; 1990; 36(3):589-99. PubMed ID: 2234402
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuroprotective effects of MK-801, TCP, PCP and CPP against N-methyl-D-aspartate induced neurotoxicity in an in vivo perinatal rat model.
    McDonald JW; Silverstein FS; Johnston MV
    Brain Res; 1989 Jun; 490(1):33-40. PubMed ID: 2667694
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The calcium channel blocker nifedipine attenuates slow excitatory amino acid neurotoxicity.
    Weiss JH; Hartley DM; Koh J; Choi DW
    Science; 1990 Mar; 247(4949 Pt 1):1474-7. PubMed ID: 2157282
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of excitotoxic profiles of ATPA, AMPA, KA and NMDA in organotypic hippocampal slice cultures.
    Kristensen BW; Noraberg J; Zimmer J
    Brain Res; 2001 Oct; 917(1):21-44. PubMed ID: 11602227
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.